iBio, Inc.
For the period ended Jun 30, 2026. Filed Aug 28, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed Aug 28, 2026
IBIO$0.78-1.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets – June 30, 2026 and 2025
Consolidated Balance Sheets** **
(In Thousands, except share and per share amounts)
| | | | | | | |
|---|---|---|---|---|---|---|
| · · June 30, · · June 30, | ||||||
| · · 2026 · · 2025 | ||||||
| · · · · | ||||||
| Assets | | | | | | |
| Current assets: | | | | | | |
| Cash and cash equivalents | | $56,395 | | $8,582 | ||
| Accounts receivable - trade, net of allowance for credit losses of $65 and $0 as of June 30, 2026 and June 30, 2025, respectively | | — | | — | ||
| Investments in debt securities (adjusted cost $31,689 and $0 as of June 30, 2026 and June 30, 2025, respectively - see Note 6) | | 31,644 | | — | ||
| Subscription receivable | | | — | | | 105 |
| Promissory note receivable and accrued interest | | | 1,104 | | | — |
| Prepaid expenses and other current assets | | 3,078 | | 1,034 | ||
| Total Current Assets | | 92,221 | | 9,721 | ||
| | | | | | ||
| Restricted cash | | | 228 | | | 210 |
| Promissory note receivable and accrued interest | | | — | | | 1,098 |
| Finance lease right-of-use assets, net of accumulated amortization | | — | | 68 | ||
| Operating lease right-of-use asset, net of accumulated amortization | | | 1,667 | | | 2,051 |
| Fixed assets, net of accumulated depreciation | | 3,086 | | 3,163 | ||
| Intangible assets, net of accumulated amortization | | | 1,825 | | | 6,848 |
| Prepaid expenses - noncurrent | | | 73 | | | — |
| Security deposits | | | 10 | | | 26 |
| Total Assets | | $99,110 | | $23,185 | ||
| | | | | | ||
| Liabilities and Stockholders' Equity | | | | | ||
| Current liabilities: | | | | | ||
| Accounts payable | | $4,423 | | $2,188 | ||
| Accrued expenses | | 5,626 | | 1,345 | ||
| Finance lease obligations | | | — | | | 53 |
| Operating lease obligation - current portion | | | 546 | | | 490 |
| Equipment financing payable - current portion | | | — | | | 64 |
| Term promissory note | | | — | | | 766 |
| Contract liabilities | | | 1,150 | | | 1,200 |
| Total Current Liabilities | | 11,745 | | 6,106 | ||
| | | | | | ||
| Operating lease obligation - net of current portion | | | 1,652 | | | 2,199 |
| Total Liabilities | | 13,397 | | 8,305 | ||
| | | | | | ||
| Stockholders' Equity | | | | | ||
| Preferred Stock - $0.001 par value; 1,000,000 shares authorized; 0 shares issued and outstanding (see Note 16) | | — | | — | ||
| Common Stock - $0.001 par value; 275,000,000 shares authorized; 55,698,561 and 19,349,201 shares issued and outstanding as of June 30, 2026 and June 30, 2025, respectively | | 56 | | | 19 | |
| Additional paid-in capital | | 450,970 | | | 347,085 | |
| Accumulated other comprehensive loss | | (45) | | | — | |
| Accumulated deficit | | | (365,268) | | | (332,224) |
| Total Stockholders’ Equity | | 85,713 | | 14,880 | ||
| Total Liabilities and Stockholders' Equity | | $99,110 | | $23,185 | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.